Devil's Claw Research

Devil's Claw Research

In an open clinical study 259 patients, who had at least a joint or a body part giving slight to moderate rheumatic problems were treated with two A.Vogel Devil's Claw Tablets over a period of 8 weeks.

Once the treatment was complete, 26% of the patients who took painkillers for their rheumatic conditions were able to stop taking this medication completely and an additional 45% were able to reduce the dose. For each painful joint or each body part, the severity of the pain was recorded by means of a Visual Analogue Scale on a scale of 0 (no problems) to 10 (very severe problems). A significant improvement was shown in all conditions. General pain levels sunk from 4.9 to 3.3, and general stiffness decreased from 5.1 to 3.1. In individual joints, pain significantly decreased by between 36 to 58%, and back pain was reduced significantly by about 37%.

Effectiveness was assessed by doctors and patients as being very good and the tolerability was rated by 87% as good. 74.3% of the participants said that they would take the tablets again. The study showed that A.Vogel Devil's Claw Tablets are a very effective and tolerable basic therapy for patients with mild to moderate rheumatic problems.